• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA22-60/I13-40
Device Problems Partial Blockage (1065); Occlusion Within Device (1423); Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017)
Patient Problems Occlusion (1984); Pain (1994); Thrombus (2101)
Event Date 05/29/2018
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with an afx to treat aortic disease.Six years after the original implant the patient had a follow up angiogram for leg pain where it was found the patient had an occlusion of the right limb.The physician performed a secondary procedure two days post angiogram via left side access.The physician found the clot and occlusion were distal of the graft which was resolved via balloon.The operation was successful, and the patient is scheduled to be discharged (b)(6) 2018.Currently, there has been no further reports of negative patient sequelae.
 
Manufacturer Narrative
Based on the clinical assessment performed the reported right iliac limb occlusion complaint is confirmed.A definitive root cause was unable to be determined for the reported event; however, the event is most likely anatomy related (pre-existing aorto-iliac occlusive disease).Procedure related harms for this complaint could not be determined based on the information shared with endologix to review.The final patient status was not reported.Additionally, clinical assessment determined that there was evidence to reasonable suggest bilateral iliac stents were present (unknown when stents were placed) occurred that was not included in the event as reported.The bilateral iliac stents were discovered on (b)(6) 2018 during review of the 67-month post implant angiogram study.The device remains implanted in the patient; therefore, device evaluation will not be completed.The review of manufacturing lot confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key7639616
MDR Text Key112423310
Report Number2031527-2018-00558
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/14/2014
Device Model NumberBA22-60/I13-40
Device Catalogue NumberF00406
Device Lot NumberW11-3866R-003
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/30/2018
Initial Date FDA Received06/26/2018
Supplement Dates Manufacturer Received05/30/2018
Supplement Dates FDA Received03/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-